Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CONMED Corp Director's Dealing 2021

Feb 5, 2021

31971_dirs_2021-02-05_303b883d-5d9d-479c-a6c8-560f9e266460.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-12-31

Reporting Person: Peters Stanley W III (VP GM Advanced Surgery)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-12-31 401 (K) Plan J 151.337 $112.00 Acquired 1084.622 Indirect

Footnotes

F1: As of December 31, 2020.

F2: No change in holdings other than as a result of a change in the shares of stock in the 401(K) Conmed fund.